Business
Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025
~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed, Value-Based, Data-Driven Decisions ~ ~ Ensysce Biopharma Leader to Deliver Opening Remarks and Present Case Study on Launching ...
About this update from Ensysce Biosciences, Inc.
[{"type":"text","content":"~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed, Value-Based, Data-Driven Decisions ~","length":160,"tagName":"p"},{"type":"text","content":"~ Ensysce Biopharma Leader to Deliver Opening Remarks and Present Case Study on Launching Successful Brands ~","length":109,"tagName":"p"},{"type":"text","content":"SAN DIEGO, CA / ACCESS Newswire / August 19, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), a clinical-stage company pioneering novel solutions for severe pain with built-in abuse and overdose protection, today announced that Geoff Birkett, Chief Commercial Officer of Ensysce, will chair the Fierce New Product Planning Summit 2025, held September 8-11, 2025 at the Pennsylvania Convention Center in Philadelphia.","length":415,"tagName":"p"},{"type":"text","content":"Mr. Birkett, recognized for his expertise in product launches and commercial strategy, will deliver the Opening Remarks, set the tone of the meeting, and present a case study on the launch process and how to maximize success.","length":225,"tagName":"p"},{"type":"text","content":"New Product Planning Summit, Tailored Product Commercialization Strategies","length":74,"tagName":"p"},{"type":"text","content":"The Fierce New Product Planning Summit is the premier industry event for defining how new product planning teams and related functions make informed, value-based, data-driven decisions to ensure commercial success of products in development. Life science leaders convene annually to share insights on maximizing pipeline potential through disciplined strategy and execution. Please find more information here.","length":409,"tagName":"p"},{"type":"text","content":"Geoff Birkett, Chief Commercial Officer Ensysce","length":47,"tagName":"p"},{"type":"text","content":"Mr. Birkett successfully brought to market several groundbreaking medicines in pain, addiction, and neuroscience. At Ensysce, he is currently spearheading preparations for the launch of the Company's first-in-class analgesic, PF614, and shaping a portfolio of innovative therapies to combat severe pain while reducing the risks of abuse and overdose.","length":354,"tagName":"p"},{"type":"text","content":"Throughout his career, Mr. Birkett has led development and commercialization teams from early-phase programs through launch and lif...